T. Rowe Price Investment Management, Inc. Icu Medical Inc Transaction History

T. Rowe Price Investment Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$81.08 - $119.29 $152 Million - $224 Million	-1,875,671 Reduced 80.92%	442,403 $44.1 Million
Q3 2023 Nov 14, 2023	SELL	$115.27 - $182.23 $8.34 Million - $13.2 Million	-72,323 Reduced 3.03%	2,318,074 $276 Million
Q2 2023 Aug 14, 2023	SELL	$161.03 - $209.15 $4.66 Million - $6.06 Million	-28,967 Reduced 1.2%	2,390,397 $426 Million
Q1 2023 May 15, 2023	SELL	$153.15 - $198.21 $591,771 - $765,883	-3,864 Reduced 0.16%	2,419,364 $399 Million
Q4 2022 Feb 14, 2023	SELL	$136.25 - $165.56 $7.58 Million - $9.21 Million	-55,633 Reduced 2.24%	2,423,228 $382 Million
Q3 2022 Nov 14, 2022	BUY	$149.44 - $188.1 $370 Million - $466 Million	2,478,861 New	2,478,861 $373 Million

313

23.8M

67.6K

37.1K

Ticker ICUI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 23,899,400
Market Cap $3.51B
Description
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and Swa...

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.